Skip to main content

Day: November 29, 2023

Blink Charging to Provide Mack Trucks’ Customers with Fleet EV Infrastructure

Mack Trucks’ customers will now have access to Blink’s EV equipment specially designed and optimized for fleets. Miami Beach, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced it has been selected as a full-service EV infrastructure provider for Mack Trucks through Mack’s Vendor Direct Ship and Turnkey Solutions program. Mack Trucks selected Blink and its reliable, scalable EV equipment and extensive fleet expertise. As operators look to electrify their fleets, Blink and its advanced EV charging products provide dedicated expertise to help accurately assess particular fleet needs to optimize infrastructure services and provide end-to-end software...

Continue reading

Tingo Group Receives Nasdaq Request for Information Following Expiry of Securities & Exchange Commission’s Temporary Suspension of Trading in the Company’s Securities

MONTVALE, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) — Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”), a profitable, multi-national fintech, agri-fintech, food processing and commodity trading company, today announced it has received a request for information from The Nasdaq Stock Market (“Nasdaq”). While the temporary suspension of trading in the Company’s Securities imposed by the Securities & Exchange Commission on November 14, 2023 expired at 11:59 pm EST on November 28, 2023, Nasdaq have advised they will continue to keep the Company’s securities halted pending their review of the requested information. The Company intends to make its response to Nasdaq’s information request within the next 3 to 4 business days and will fully cooperate with Nasdaq to assist them in completing their review as quickly as possible,...

Continue reading

Society Pass Inc (Nasdaq: SOPA) / NusaTrip Inc Partners with Vietnam-based Travel Platform, VN Travel Group, to Jointly Market to Vietnamese Customers

JAKARTA, Indonesia, Nov. 29, 2023 (GLOBE NEWSWIRE) — NusaTrip (“NusaTrip”), the online travel platform of Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce ecosystem, announces strategic partnership with VNTravel Group (“VNTravel”), which enables NusaTrip to directly supply regional and international flights and hotels to VNTravel’s Vietnamese customers. As the leading travel technology company in Vietnam over the last 11 years, VNTravel offers over 30,000 premium accommodation options and partners with more than 200 global airlines. VNTravel reaches various customer segments through different sales channels: domestic retail via Mytour.vn, international retail through Dinogo.com, travel agencies via Tripi.vn, and other B2B2C channels. To...

Continue reading

Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook

HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that CEO George Ng has issued a letter to shareholders. Dear Processa Pharmaceuticals Shareholders: Following Processa’s business pivot to focus on oncology drug product development, I was recently appointed as Processa’s CEO, and I thought it would be helpful for investors to get a corporate update from a new voice at the Company. I joined Processa not with the intent to change the Company’s current strategic course, but rather, I intend to apply my background and expertise to complement the strong clinical and regulatory...

Continue reading

Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification

MINNEAPOLIS, Nov. 29, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announces that the independent Data Safety Monitoring Board (DSMB) of the Phase 3 ASPIRE clinical trial for patients with untreated metastatic pancreatic ductal adenocarcinoma has completed its pre-specified review of safety data for treated patients which included 214 patients in the trial. The DSMB has recommended that the study continue without modification. The ASPIRE Trial is a global randomized, double-blind placebo-controlled clinical trial to evaluate ivospemin in combination with gemcitabine and nab-Paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma. “We are pleased that no safety concerns...

Continue reading

Siili Solutions Plc Financial calendar and annual general meeting 2024

Siili Solutions Plc Financial calendar and annual general meeting 2024 Siili Solutions Plc Stock Exchange Release 29 November 2023 at 15:15 EET Siili Solutions Plc publishes its financial reports in 2024 as follows:Financial statement bulletin for 2023 on Tuesday 27 February 2024 Annual report 2023 on week 10  Business review for January-March 2024 on Tuesday 24 April 2024  Half-yearly report for January-June on Tuesday 13 August 2024  Business review for January-September on 22 October 2024 Financial statement bulletin 2023 and half-yearly report for 2024 will be published on or about 9:00 am. Business reviews will be published on the abovementioned days on or about 10:00 am at the latest. The annual general meeting of Siili Solutions Plc is planned to be held on Wednesday 3 April 2024 in Helsinki, Finland. In addition, the company...

Continue reading

Robex Announces Its Third Quarter Results 2023

QUEBEC CITY, Nov. 29, 2023 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company”) (TSXV: RBX) presents today its operational and financial results for the third quarter ended September 30, 2023. Aurélien Bonneviot, Chief Executive Officer: “Another strong set of operating results at Nampala, demonstrating the incredible dedication of the enlarged management team since the beginning of the year. Nampala’s operation performance continue to support the development of the group towards becoming a mid-tier gold producer in West Africa. We are on-track to deliver our 2023 guidance on production and costs1. We would like to thank all Robex employees for their hard work.” Unless otherwise noted, all amounts and financials in this press release are presented in Canadian dollars (CAD). SUMMARY OF HIGHLIGHTS...

Continue reading

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

— Company on track to submit PAS-004 IND application in current quarter — — Pasithea plans to begin PAS-004 Phase 1 dose escalation trial in advanced solid tumor patients harboring RAS, RAF and NF1 mutations — SOUTH SAN FRANCISCO, Calif. and MIAMI, Nov. 29, 2023 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for Central Nervous System (CNS) disorders, announced receipt of written responses to questions submitted for a Type 2 pre-Investigational New Drug Application (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding clinical development plan for PAS-004. The FDA’s positive feedback and guidance include a recommendation to begin dosing...

Continue reading

Water Ways Appoints Mr. Asi Levi as Chief Financial Officer

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (“Water Ways” or the “Company“), is pleased to announce, that effective November 26, 2023, the appointment of Mr. Asi Levi as Water Ways’ CFO. Mr. Levi will be replacing Mr. Dor Sneh, who will continue to provide consulting services to the Company. Mr. Levi, who holds a B.A in Business Management and Accounting from the College of Management, Rishon LeZion, received his Certified Public Accountant designation in Israel. Mr. Levi has over 6 years of experience working with public US, Canadian and multi-jurisdictional public companies. Mr. Levi began his career in public accounting at Deloitte. Ohad Haber, the Company’s Chairman...

Continue reading

Mosaic Minerals Completes Drilling on Gaboury and Announces $500,000 Financing

Gaboury Drilling ResultsGaboury Drilling ResultsMONTREAL, Nov. 29, 2023 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces that it has completed eight drill holes for a total of 2,475 meters on its Gaboury nickel project located in Témiscamingue, Quebec. Three drillings were carried out on the Pike West showing while three other drillings were carried out on the Pike East showing and another drilling in the Pike Center area. A last drilling was carried out to test a magnetic anomaly located north of the Pike West area. The majority of these drill holes intersected the desired mineralized zones over widths varying from 40 meters to more than 150 meters. Comprised of three nickel showings, the Pike zone has been traced by drilling for more than 4.5 kilometers to date. In addition...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.